Immunocore Holdings (IMCR) Receivables (2022 - 2025)
Historic Receivables for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $75.9 million.
- Immunocore Holdings' Receivables rose 1922.9% to $75.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 1922.9%. This contributed to the annual value of $63.0 million for FY2024, which is 2095.48% up from last year.
- Per Immunocore Holdings' latest filing, its Receivables stood at $75.9 million for Q3 2025, which was up 1922.9% from $69.8 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Receivables ranged from a high of $75.9 million in Q3 2025 and a low of $7.3 million during Q4 2021
- Its 5-year average for Receivables is $54.6 million, with a median of $61.6 million in 2024.
- Its Receivables has fluctuated over the past 5 years, first skyrocketed by 35792.2% in 2022, then soared by 925.65% in 2025.
- Over the past 5 years, Immunocore Holdings' Receivables (Quarter) stood at $7.3 million in 2021, then skyrocketed by 357.92% to $33.6 million in 2022, then soared by 55.11% to $52.1 million in 2023, then rose by 20.95% to $63.0 million in 2024, then rose by 20.46% to $75.9 million in 2025.
- Its last three reported values are $75.9 million in Q3 2025, $69.8 million for Q2 2025, and $63.1 million during Q1 2025.